John C Boyd insider trades: Chad Therapeutics (CTU) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 24, 2006 | CTU | ↓ Sell | 2,473 | $3.01 | $7K | Direct | Nov 27, 2006 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John C Boyd's insider trades
John C Boyd is a director at Chad Therapeutics (CTU). Since Nov 24, 2006, John has reported no open-market purchases and 1 sale worth $7K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.